IRIS publication 160957437
Treatment of neonatal seizures
RIS format for Endnote and similar
TY - JOUR - Book Reviews - Rennie, J,Boylan, G - 2007 - March - Treatment of neonatal seizures - Validated - 1 - () - DEVELOPING RAT-BRAIN CEREBRAL-BLOOD-FLOW ANTIEPILEPTIC DRUGS RECURRENT SEIZURES STATUS EPILEPTICUS IMMATURE RATS TOPIRAMATE EPILEPSY - Newborn babies with unusual movements thought to represent seizures are usually given a loading dose of phenobarbitone without electroencephalography being performed. Antlepileptic drugs (AEDs) are then continued, with the outcome determined by clinical observation alone. AED treatment, often involving multiple drugs for long periods, is undesirable at a time when the brain is developing rapidly and likely to be especially vulnerable to any toxic effects. Despite considerable advances in the pharmacology of AEDs, continuous EEG monitoring using compact digital systems with simultaneous videorecording allowing off-line analysis, automated seizure detection, neuroimaging, and basic science research on cellular mechanisms of brain injury, treatment of such babies has progressed little. A change in practice is long overdue to allow affected babies to benefit from the advances made. - 148 - 150 - DOI 10.1136/adc.2004.068551 DA - 2007/03 ER -
BIBTeX format for JabRef and similar
@review{V160957437, = {Book Reviews}, = {Rennie, J and Boylan, G }, = {2007}, = {March}, = {Treatment of neonatal seizures}, = {Validated}, = {1}, = {()}, = {DEVELOPING RAT-BRAIN CEREBRAL-BLOOD-FLOW ANTIEPILEPTIC DRUGS RECURRENT SEIZURES STATUS EPILEPTICUS IMMATURE RATS TOPIRAMATE EPILEPSY}, = {{Newborn babies with unusual movements thought to represent seizures are usually given a loading dose of phenobarbitone without electroencephalography being performed. Antlepileptic drugs (AEDs) are then continued, with the outcome determined by clinical observation alone. AED treatment, often involving multiple drugs for long periods, is undesirable at a time when the brain is developing rapidly and likely to be especially vulnerable to any toxic effects. Despite considerable advances in the pharmacology of AEDs, continuous EEG monitoring using compact digital systems with simultaneous videorecording allowing off-line analysis, automated seizure detection, neuroimaging, and basic science research on cellular mechanisms of brain injury, treatment of such babies has progressed little. A change in practice is long overdue to allow affected babies to benefit from the advances made.}}, pages = {148--150}, = {DOI 10.1136/adc.2004.068551}, source = {IRIS} }
Data as stored in IRIS
OTHER_PUB_TYPE | Book Reviews | ||
AUTHORS | Rennie, J,Boylan, G | ||
YEAR | 2007 | ||
MONTH | March | ||
TITLE | Treatment of neonatal seizures | ||
RESEARCHER_ROLE | |||
STATUS | Validated | ||
PEER_REVIEW | 1 | ||
TIMES_CITED | () | ||
SEARCH_KEYWORD | DEVELOPING RAT-BRAIN CEREBRAL-BLOOD-FLOW ANTIEPILEPTIC DRUGS RECURRENT SEIZURES STATUS EPILEPTICUS IMMATURE RATS TOPIRAMATE EPILEPSY | ||
REFERENCE | |||
ABSTRACT | Newborn babies with unusual movements thought to represent seizures are usually given a loading dose of phenobarbitone without electroencephalography being performed. Antlepileptic drugs (AEDs) are then continued, with the outcome determined by clinical observation alone. AED treatment, often involving multiple drugs for long periods, is undesirable at a time when the brain is developing rapidly and likely to be especially vulnerable to any toxic effects. Despite considerable advances in the pharmacology of AEDs, continuous EEG monitoring using compact digital systems with simultaneous videorecording allowing off-line analysis, automated seizure detection, neuroimaging, and basic science research on cellular mechanisms of brain injury, treatment of such babies has progressed little. A change in practice is long overdue to allow affected babies to benefit from the advances made. | ||
PUBLISHER_LOCATION | |||
PUBLISHER | |||
EDITORS | |||
ISBN_ISSN | |||
EDITION | |||
URL | |||
START_PAGE | 148 | ||
END_PAGE | 150 | ||
DOI_LINK | DOI 10.1136/adc.2004.068551 | ||
FUNDING_BODY | |||
GRANT_DETAILS |